Lixte Biotechnology Holdings reports that Strategic EP, LLC and Alexander Chase Deitch together beneficially own 5.1% (774,902 shares) of Common Stock. The filing states the percentage is based on June 2, 2026 outstanding share count of 15,278,806, as reported in the Issuer's Prospectus on Form 424B5 filed June 4, 2026. The disclosure notes 545,521 warrants are issuable but contain a provision preventing exercise to the extent it would push ownership above 4.99%. The Reporting Persons filed a Joint Filing Agreement and signed the Schedule 13G on June 9, 2026.
Positive
None.
Negative
None.
Insights
Holders disclosed a passive beneficial stake of 5.1% in Lixte.
The Schedule 13G lists 774,902 shares attributed jointly to Strategic EP, LLC and Alexander Chase Deitch, using an outstanding share base of 15,278,806 as of June 2, 2026. The filing includes a Joint Filing Agreement signed by the reporting parties.
The excerpt also flags 545,521 warrants with an anti‑ownership provision capping exercise at 4.99%, which constrains immediate dilution from warrant exercise; subsequent disclosures would be needed for any ownership changes.
Disclosure is routine for beneficial holders around a prospectus-related offering.
The filing ties the ownership percentage to the issuer's Prospectus on Form 424B5 filed June 4, 2026, indicating the ownership calculation uses that prospectus' outstanding share count. The Schedule 13G form type signals a passive reporting status rather than an active acquisition intent.
Because the warrants include a 4.99% exercise cap, the potential for near-term share increase from those warrants is limited by contract language; any change in actual holdings would appear in subsequent filings.
Key Figures
Shares beneficially owned:774,902 sharesPercent of class:5.1%Shares outstanding:15,278,806 shares+2 more
5 metrics
Shares beneficially owned774,902 sharesAmount reported as beneficially owned by Strategic EP and Mr. Deitch
Percent of class5.1%Reported ownership percentage based on outstanding shares as of <date>June 2, 2026</date>
Shares outstanding15,278,806 sharesOutstanding share count used for calculation as of <date>June 2, 2026</date>
Warrants issuable545,521 warrantsWarrants noted in the filing with an exercise limitation
Warrant exercise cap4.99%Provision preventing exercise if ownership would exceed <percent>4.99%</percent>
"The Reporting Persons have entered into a Joint Filing Agreement"
A Schedule 13G is a formal document that investors file with the government when they acquire a large ownership stake in a company, usually for investment purposes rather than control. It helps keep the public informed about who owns significant parts of a company's shares, which can influence how the company is managed and how investors make decisions. Filing this schedule is important for transparency and understanding the ownership landscape of publicly traded companies.
beneficially ownedfinancial
"Amount beneficially owned: 774,902 shares of Common Stock"
Beneficially owned describes securities or assets where a person has the economic rights and control—such as the right to receive dividends and to direct voting—even if legal title is held in another name. Think of it like having the keys and using a car that’s registered to someone else: you get the benefits and make decisions. Investors care because beneficial ownership reveals who truly controls value and voting power, affecting corporate decisions and takeover dynamics.
Rule 13d-3regulatory
"By reason of the provisions of Rule 13d-3 of the Act"
Rule 13d-3 defines who is treated as the beneficial owner of a company’s shares for U.S. securities disclosure rules — essentially anyone who has the power to vote or direct how shares are voted, or the power to buy or sell them, even if they don’t hold the certificates. For investors this matters because crossing certain ownership thresholds triggers public filing and disclosure obligations and signals potential control or influence, much like having the keys to a car implies you can drive it even if it’s registered to someone else.
Joint Filing Agreementlegal
"A copy of which is filed as Exhibit 1 to this"
See more from StockTitan in Google Search and AI answers.Adds StockTitan as a preferred source · opens Google
What stake did Strategic EP and Alexander Deitch report in LIXT?
They reported beneficial ownership of 774,902 shares, representing 5.1% of Common Stock based on June 2, 2026 outstanding shares of 15,278,806, per the prospectus cited in the filing.
Does the filing show warrants that could increase holdings for the reporting parties?
Yes. The filing states 545,521 warrants are issuable, but the warrants include a provision preventing exercise if it would raise ownership above 4.99%, limiting immediate increases from those warrants.
What form was used to disclose the ownership and when was it signed?
The ownership was reported on a Schedule 13G with a Joint Filing Agreement attached; the signatures are dated June 9, 2026, and the prospectus referenced was filed June 4, 2026.
How was the percentage ownership calculated in the filing?
The filing states the percentage is based on an outstanding share count of 15,278,806 shares as of June 2, 2026, taken from the Issuer's Prospectus on Form 424B5 filed June 4, 2026.
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 13G
UNDER THE SECURITIES EXCHANGE ACT OF 1934
LIXTE BIOTECHNOLOGY HOLDINGS, INC.
(Name of Issuer)
Common Stock, par value $0.0001 per share
(Title of Class of Securities)
539319301
(CUSIP Number)
06/04/2026
(Date of Event Which Requires Filing of this Statement)
Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)
schemaVersion:
SCHEDULE 13G
CUSIP Number(s):
539319301
1
Names of Reporting Persons
Strategic EP, LLC
2
Check the appropriate box if a member of a Group (see instructions)
(a)
(b)
3
Sec Use Only
4
Citizenship or Place of Organization
DELAWARE
Number of Shares Beneficially Owned by Each Reporting Person With:
5
Sole Voting Power
0.00
6
Shared Voting Power
774,902.00
7
Sole Dispositive Power
0.00
8
Shared Dispositive Power
774,902.00
9
Aggregate Amount Beneficially Owned by Each Reporting Person
774,902.00
10
Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)
11
Percent of class represented by amount in row (9)
5.1 %
12
Type of Reporting Person (See Instructions)
OO
SCHEDULE 13G
CUSIP Number(s):
539319301
1
Names of Reporting Persons
Alexander Chase Deitch
2
Check the appropriate box if a member of a Group (see instructions)
(a)
(b)
3
Sec Use Only
4
Citizenship or Place of Organization
UNITED STATES
Number of Shares Beneficially Owned by Each Reporting Person With:
5
Sole Voting Power
0.00
6
Shared Voting Power
774,902.00
7
Sole Dispositive Power
0.00
8
Shared Dispositive Power
774,902.00
9
Aggregate Amount Beneficially Owned by Each Reporting Person
774,902.00
10
Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)
11
Percent of class represented by amount in row (9)
5.1 %
12
Type of Reporting Person (See Instructions)
IN
SCHEDULE 13G
Item 1.
(a)
Name of issuer:
LIXTE BIOTECHNOLOGY HOLDINGS, INC.
(b)
Address of issuer's principal executive offices:
433 Plaza Real, Suite 275, Boca Raton, Florida 33432
Item 2.
(a)
Name of person filing:
(i) Strategic EP, LLC, a Delaware limited liability company ("Strategic"); and
(ii) Alexander Chase Deitch ("Mr. Deitch").
The foregoing persons are hereinafter collectively referred to as the "Reporting Persons". Any disclosures herein with respect to persons other than the Reporting Persons are made on information and belief after making inquiry to the appropriate party.
The Reporting Persons have entered into a Joint Filing Agreement, a copy of which is filed as Exhibit 1 to this Schedule 13G, pursuant to which such Reporting Persons have agreed to file this Schedule 13G and all subsequent amendments to the Schedule 13G jointly in accordance with the provisions of Rule 13d-1(k) of the Act.
The filing of this Schedule 13G should not be construed in and of itself as an admission by any Reporting Person as to beneficial ownership of the Common Stock reported herein.
(b)
Address or principal business office or, if none, residence:
The principal business address of each of the Reporting Persons is 1050 Crowne Pointe Parkway, Suite 500, Atlanta, GA 30338.
(c)
Citizenship:
Strategic is a limited liability company organized under the laws of the State of Delaware. Mr. Deitch is a citizen of the United States.
(d)
Title of class of securities:
Common Stock, par value $0.0001 per share
(e)
CUSIP Number(s):
539319301
Item 3.
If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:
(a)
Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o);
(b)
Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c);
(c)
Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c);
(d)
Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8);
(e)
An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E);
(f)
An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F);
(g)
A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);
(h)
A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
(i)
A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
(j)
A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J). If filing as a non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J),
please specify the type of institution:
(k)
Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K).
Item 4.
Ownership
(a)
Amount beneficially owned:
774,902 shares of Common Stock (the "Shares").
Strategic has the power to dispose of and the power to vote the Shares beneficially owned by it, which power may be exercised by its manager, Mr. Deitch. Mr. Deitch does not directly own the Shares. By reason of the provisions of Rule 13d-3 of the Act, Mr. Deitch may be deemed to beneficially own the Shares which are beneficially owned by Strategic.
Does not include 545,521 shares of Common Stock issuable upon exercise of warrants. These warrants contain a provision, which precludes the exercise of the warrants to the extent that, following exercise, the Reporting Person would own more than 4.99% of the Common Stock outstanding.
The share amounts and ownership percentages reported are based on 15,278,806 shares of Common Stock outstanding as of June 2, 2026, as reported in the Issuer's Prospectus on Form 424B5 filed with the SEC on June 4, 2026.
(b)
Percent of class:
5.1%
(c)
Number of shares as to which the person has:
(i) Sole power to vote or to direct the vote:
0
(ii) Shared power to vote or to direct the vote:
774,902
(iii) Sole power to dispose or to direct the disposition of:
0
(iv) Shared power to dispose or to direct the disposition of:
774,902
Item 5.
Ownership of 5 Percent or Less of a Class.
Not Applicable
Item 6.
Ownership of more than 5 Percent on Behalf of Another Person.
Not Applicable
Item 7.
Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.
Not Applicable
Item 8.
Identification and Classification of Members of the Group.
Not Applicable
Item 9.
Notice of Dissolution of Group.
Not Applicable
Item 10.
Certifications:
By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under § 240.14a-11.
SIGNATURE
After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.
Strategic EP, LLC
Signature:
/s/ Alexander Chase Deitch
Name/Title:
Alexander Chase Deitch, Manager
Date:
06/09/2026
Alexander Chase Deitch
Signature:
/s/ Alexander Chase Deitch
Name/Title:
Alexander Chase Deitch
Date:
06/09/2026
Exhibit Information
Exhibit 1: Joint Filing Agreement, dated June 9, 2026, by and between Strategic EP, LLC and Alexander Chase Deitch
